Ovarian & Prostate Ca
12 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Rescooped by oncdoc7 from PARP Inhibitors Cancer Review
Scoop.it!

Dr. Aghajanian Discusses PARP Inhibitors for the Treatment of ...

Dr. Aghajanian Discusses PARP Inhibitors for the Treatment of Ovarian Cancer Carol Aghajanian, MD, from the Memorial Sloan-Kettering Cancer Center, discusses the treatment of ovarian cancer with PARP inhibitors.

Via Krishan Maggon
more...
No comment yet.
Rescooped by oncdoc7 from PARP Inhibitors Cancer Review
Scoop.it!

Amgen's trebananib met trial goal, reduces risk of ovarian cancer ...

Amgen's trebananib met trial goal, reduces risk of ovarian cancer ... | Ovarian & Prostate Ca | Scoop.it
Amgen Inc said that its trebananib treatment for ovarian cancer had reduced the risk of disease progression or death by 34 percent in a clinical trial.

Via Krishan Maggon
more...
No comment yet.
Scooped by oncdoc7
Scoop.it!

Maintenance Therapy with Votrient Provides Benefit in Advanced ...

In a Phase III clinical trial, treatment with Votrient® (pazopanib) after initial chemotherapy improved outcomes among women with advanced ovarian cancer. These results were presented at the 2013 Annual Meeting of the American Society of ...
more...
No comment yet.